TGA approves next generation diabetes drug Mounjaro

Will Eli Lilly’s potential blockbuster get the same social media weight-loss attention as shortage plagued Ozempic? The next generation of Type-2 diabetes drugs – and by extension weight-loss drugs – is now firmly with us with the TGA’s decision just before Christmas to approve Eli Lilly’s much-anticipated Mounjaro for use for Type-2 diabetes. That listing,

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Pharmacist vaccination gives evidence to back prescribing role
Next ‘Ahpra can absolutely take action.’